title: Hospital care of patients with ST-elevation myocardial infarction in four different European regions. Data from four regional myocardial infarction registries in Berlin, Dijon, Florence, and Tartu.
abstract: National surveys as well as European comparative studies suggest that differences in treatment of patients with ST-elevation myocardial infarction (STEMI) exist. The extent to which these variations influence the outcome of hospital care delivered to STE-MI patients in everyday routine is mostly unknown. In this study data representative of hospital care received by STEMI patients in four European regions (Berlin, Dijon, Florence and Tartu) were compared. The four registries are population based. The percentage of women and the mean age of the patients differed among the registries. Risk factors such as hypertension and hypercholesterolaemia also differed among the different regions, whereas a history of diabetes mellitus was similar among the registries. The percentage of patients receiving reperfusion therapy ranged from 47 to 81%. An appreciable difference also resulted after breaking down reperfusion therapy into thrombolysis and primary percutaneous coronary intervention (PCI). Hospital mortality as an outcome measure was very similar among the regions. After adjustment for age, the comparative magnitude of hospital mortality proportion was also very similar among three registries. Only the patients from Florence demonstrated a comparatively lower death rate, with a ratio of 0.81. In summary, there are important differences among baseline characteristics and hospital care of STE-Ml patients in the four study regions. Nevertheless, it was interesting to ascertain that the outcome measured in hospital mortality was very similar among the four registries compared.
authors.affiliation: Berliner Herzinfarkt Register, Berlin. birga.maier@tu-berlin.de
authors.forename: R
authors.initials: R
authors.lastname: Maier
authors.forename: D
authors.initials: D
authors.lastname: Balzi
authors.forename: T
authors.initials: T
authors.lastname: Ainla
authors.forename: M
authors.initials: M
authors.lastname: Zeller
authors.forename: G
authors.initials: G
authors.lastname: Kallischnigg
authors.forename: A
authors.initials: A
authors.lastname: Barchielli
authors.forename: R
authors.initials: R
authors.lastname: Teesalu
authors.forename: Y
authors.initials: Y
authors.lastname: Cottin
authors.forename: H
authors.initials: H
authors.lastname: Theres
authors.forename: E
authors.initials: E
authors.lastname: Buiatti
authors.forename: J
authors.initials: J
authors.lastname: Eha
authors.forename: J C
authors.initials: JC
authors.lastname: Beer
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary; D001604:Berlin; D004562:Electrocardiography; D004957:Estonia; D005260:Female; D005602:France; D017052:Hospital Mortality; D006760:Hospitalization; D006801:Humans; D007558:Italy; D008017:Life Expectancy; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D015425:Myocardial Reperfusion; D012008:Recurrence; D012042:Registries; D012307:Risk Factors; D015912:Thrombolytic Therapy; D016896:Treatment Outcome